CI
ARRY

Cambiar Investors’s Array Biopharma Inc ARRY Stock Holding History

Cambiar Investors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-276,734
Closed -$4.52M – 178
2018
Q1 		$4.52M Sell
276,734
-230,336
-45% -$3.69M 0.07% 107
2017
Q4 		$6.49M Sell
507,070
-123,057
-20% -$1.4M 0.1% 103
2017
Q3 		$7.75M Sell
630,127
-452,748
-42% -$4.21M 0.12% 103
2017
Q2 		$9.06M Sell
1,082,875
-877,557
-45% -$7.18M 0.14% 105
2017
Q1 		$17.5M Buy
1,960,432
+1,160,516
+145% +$12.3M 0.29% 97
2016
Q4 		$7.03M Buy
+799,916
New +$5.89M 0.12% 101

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Cambiar Investors's ARRY Position: Q2 2018 in Review

Cambiar Investors sold out of Array Biopharma Inc (ARRY) in Q2 2018, closing a stake of 276,734 shares — an estimated $4.52M sold.

Cambiar Investors first reported a position in ARRY in Q4 2016 and held it in 6 quarters. The position peaked at $17.5M in Q1 2017. 223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

  • Cambiar Investors reported no remaining Array Biopharma Inc position as of Q2 2018 after selling out during the quarter.
  • Cambiar Investors sold 276,734 Array Biopharma Inc shares in Q2 2018, an estimated $4.52M.
  • Cambiar Investors first reported a position in Array Biopharma Inc in Q4 2016 and held it in 6 quarters.
  • Cambiar Investors's Array Biopharma Inc position peaked at $17.5M in Q1 2017.
  • 223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on Cambiar Investors's 13F filing for Q2 2018, filed 18 Jul 2018.